This inventor holds 1 USPTO granted patent. Top assignee: State of Oregon. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Robnert E Burgeson: Innovator in Keratinocyte Adhesion
Introduction
Robnert E Burgeson is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of dermatology through his innovative research and patents. His work focuses on improving keratinocyte adhesion to the dermis, which is crucial for skin health and healing.
Latest Patents
Robnert E Burgeson holds a patent for a product and method aimed at enhancing keratinocyte adhesion to the dermis. The patent describes a purified protein known as kalinin, which facilitates adhesion between epidermal keratinocytes and the underlying dermis. Kalinin is characterized by its molecular weight of approximately 400-460 kDa and exists in various forms, including a cell-associated form and two medium-associated forms. The patent also outlines a method for optimizing kalinin production from cultured keratinocytes or providing an exogenous source of kalinin to improve adhesion of transplanted keratinocytes.
Career Highlights
Throughout his career, Robnert E Burgeson has demonstrated a commitment to advancing scientific knowledge in dermatology. His innovative approach to keratinocyte adhesion has the potential to impact treatments for skin-related conditions and enhance the effectiveness of skin grafts.
Collaborations
Robnert has collaborated with esteemed colleagues such as Douglas R Keene and M Peter Marinkovich. These collaborations have further enriched his research and contributed to the development of his patented technologies.
Conclusion
Robnert E Burgeson is a pioneering inventor whose work on keratinocyte adhesion has significant implications for dermatological science. His contributions continue to influence the field and offer promising avenues for future research and application.